Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eszter Trojnar

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Nature Reviews. Cardiology|October 1, 2020
Interplay of cardiovascular mediators, oxidative stress and inflammation in liver disease and its complicationsCsaba Matyas, György Haskó, Lucas Liaudet, et al.
Infection and Immunity|January 24, 2019
Shiga Toxin Type 1a (Stx1a) Reduces the Toxicity of the More Potent Stx2a <i>In Vivo</i> and <i>In Vitro</i>Courtney D Petro, Eszter Trojnar, James Sinclair, et al.
Free Radical Biology & Medicine|November 27, 2019
Cannabinoid-2 receptor activation ameliorates hepatorenal syndromeEszter Trojnar, Katalin Erdelyi, Csaba Matyas, et al.
Geroscience|September 19, 2023
Data-driven transcriptomics analysis identifies PCSK9 as a novel key regulator in liver agingMuhammad Arif, Csaba Matyas, Partha Mukhopadhyay, et al.
Frontiers in Immunology|March 13, 2019
Elevated Systemic Pentraxin-3 Is Associated With Complement Consumption in the Acute Phase of Thrombotic MicroangiopathiesEszter Trojnar, Mihály Józsi, Zsóka Szabó, et al.
Journal of Hepatology|December 2, 2019
Interleukin-22 ameliorates acute-on-chronic liver failure by reprogramming impaired regeneration pathways in miceXiaogang Xiang, Dechun Feng, Seonghwan Hwang, et al.
Hepatology (Baltimore, Md.)|August 31, 2019
Interplay of Liver-Heart Inflammatory Axis and Cannabinoid 2 Receptor Signaling in an Experimental Model of Hepatic CardiomyopathyCsaba Matyas, Katalin Erdelyi, Eszter Trojnar, et al.
Brain, Behavior, and Immunity|April 24, 2024
PCSK9 inhibition attenuates alcohol-associated neuronal oxidative stress and cellular injuryJosephin Wagner, Lauren M Park, Partha Mukhopadhyay, et al.
Scientific Reports|November 22, 2019
PCSK9 inhibition as a novel therapeutic target for alcoholic liver diseaseJi Soo Lee, Partha Mukhopadhyay, Csaba Matyas, et al.
JACC. Basic to Translational Science|December 14, 2023
PCSK9, A Promising Novel Target for Age-Related Cardiovascular DysfunctionCsaba Matyas, Eszter Trojnar, Suxian Zhao, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Nature Reviews. Cardiology|October 1, 2020
Interplay of cardiovascular mediators, oxidative stress and inflammation in liver disease and its complicationsCsaba Matyas, György Haskó, Lucas Liaudet, et al.
Infection and Immunity|January 24, 2019
Shiga Toxin Type 1a (Stx1a) Reduces the Toxicity of the More Potent Stx2a <i>In Vivo</i> and <i>In Vitro</i>Courtney D Petro, Eszter Trojnar, James Sinclair, et al.
Free Radical Biology & Medicine|November 27, 2019
Cannabinoid-2 receptor activation ameliorates hepatorenal syndromeEszter Trojnar, Katalin Erdelyi, Csaba Matyas, et al.
Geroscience|September 19, 2023
Data-driven transcriptomics analysis identifies PCSK9 as a novel key regulator in liver agingMuhammad Arif, Csaba Matyas, Partha Mukhopadhyay, et al.
Frontiers in Immunology|March 13, 2019
Elevated Systemic Pentraxin-3 Is Associated With Complement Consumption in the Acute Phase of Thrombotic MicroangiopathiesEszter Trojnar, Mihály Józsi, Zsóka Szabó, et al.
Journal of Hepatology|December 2, 2019
Interleukin-22 ameliorates acute-on-chronic liver failure by reprogramming impaired regeneration pathways in miceXiaogang Xiang, Dechun Feng, Seonghwan Hwang, et al.
Hepatology (Baltimore, Md.)|August 31, 2019
Interplay of Liver-Heart Inflammatory Axis and Cannabinoid 2 Receptor Signaling in an Experimental Model of Hepatic CardiomyopathyCsaba Matyas, Katalin Erdelyi, Eszter Trojnar, et al.
Brain, Behavior, and Immunity|April 24, 2024
PCSK9 inhibition attenuates alcohol-associated neuronal oxidative stress and cellular injuryJosephin Wagner, Lauren M Park, Partha Mukhopadhyay, et al.
Scientific Reports|November 22, 2019
PCSK9 inhibition as a novel therapeutic target for alcoholic liver diseaseJi Soo Lee, Partha Mukhopadhyay, Csaba Matyas, et al.
JACC. Basic to Translational Science|December 14, 2023
PCSK9, A Promising Novel Target for Age-Related Cardiovascular DysfunctionCsaba Matyas, Eszter Trojnar, Suxian Zhao, et al.
Pageof 1